The 52-Week-High List: 20 Small Cap Names On Thursday
A new list of highs is concentrated in just two areas of the market, raising questions about the quality of the gains.
Twist Bioscience (TWST), the largest name on today’s list with a market value of about $9.7 billion, has gained 34.0% over the last month. As of Thursday, September 17, there are 20 Small Cap US and Canada-listed stocks in the Trefis coverage universe trading at their 52-week highs. The list is heavily weighted toward just two parts of the market. Health Care accounts for 10 names and Energy holds 5 names, leaving little room for anything else. This raises a critical question: are these highs built on durable business strength, or just price action?
The Ten Largest At New Highs
The table below shows the 10 largest of the 20 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| TWST | $9.71 Bil | 8.7% | 22.6% | 34.0% | 474.4% |
| INSW | $5.47 Bil | 1.1% | 8.2% | 17.6% | 166.1% |
| CVI | $5.44 Bil | 2.1% | 11.4% | 47.7% | 64.2% |
| CLMT | $5.17 Bil | 1.8% | 4.6% | 16.2% | 206.6% |
| DK | $5.0 Bil | 3.0% | 8.9% | 19.5% | 165.1% |
| ADPT | $4.56 Bil | 3.2% | 17.8% | 16.2% | 121.1% |
| IOVA | $4.51 Bil | 1.5% | 23.1% | 42.5% | 335.7% |
| PARR | $4.2 Bil | 1.9% | 3.5% | 7.4% | 144.1% |
| ABCL | $3.89 Bil | 9.1% | 21.7% | 14.5% | 166.9% |
| CXW | $3.51 Bil | 1.7% | 3.3% | 9.7% | 72.3% |
This screen covers US and Canada-listed stocks in the Trefis coverage universe. Small Cap here means a market value between $2 billion and $10 billion, the upper figure excluded.
What does a business at its high look like?
The numbers underneath the new highs tell different stories. International Seaways (INSW) trades at 7.0 times trailing earnings, and its revenue grew 57.4% over the last twelve months, and its operating margin was 55.7%. The figures show a business whose price is accompanied by significant top-line growth and profitability.
In contrast, CVR Energy (CVI) trades at 78.9 times trailing earnings (on trailing earnings that include at least one loss quarter, so the multiple is not comparable to a clean-year multiple), and its revenue grew 17.9% over the last twelve months, and its operating margin was 4.1%. The valuation is high, the basis note signals caution, and the underlying growth and margin are much thinner.
A high price is a question, not an answer.
A list of stocks at their strongest prices of the year is a good place to hunt for ideas. Strength can persist. But a 52-week high is a price, not a verdict on the business itself. The disciplined next step is always the same: to check whether the company’s operating results can justify the new level.
A new high tells you what the market already believes. The harder question is which of these runs management itself is underwriting. Our Guidance Momentum screen tracks exactly that: stocks where the company raised its own forward numbers.
One more pattern worth noticing: 10 of the 20 names are Health Care stocks. When a whole group is making new highs together, a biotech ETF like XBI, which holds 3 of these names, is one way to own part of the group’s strength without betting on which single name leads it from here.
Chasing Highs Is A Reflex. Owning Strength Is A System
A 52-week-high list is seductive: everything on it has been going right. But buying a stock because it is at its high is buying a price, and prices revert; what persists is the quality underneath the run.
The Trefis High Quality (HQ) Portfolio is built to own that quality before and after it makes headlines: roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Admire the list; own the system.